Tamar Raz

Dr. Tamar Raz is a seasoned expert in technology transfer and health innovation, most recently serving as the CEO of Hadasit, the technology transfer company of Hadassah Hospital in Jerusalem. She has held notable leadership roles, including co-chair of the Israel Technology Transfer Organization (ITTN) and chair of Hadasit Bio Holdings (HBL, TASE: HDST). With over 20 years of experience, Dr. Raz has a proven track record of successfully advancing medical innovations from the laboratory to the marketplace. Previously, she was the VP of Marketing and Strategy at Ramot, the technology transfer office of Tel Aviv University, and founded Allergene Ltd., an Israeli drug development start-up. Dr. Raz holds both an MSc and PhD from the Tel Aviv University School of Medicine.